Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
Saved in:
| Title: | Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. |
|---|---|
| Authors: | Capdeville R; Novartis Pharma AG, S-27 2.033, CH-4002 Basel, Switzerland. renaud.capdeville@pharma.novartis.com, Buchdunger E, Zimmermann J, Matter A |
| Source: | Nature reviews. Drug discovery [Nat Rev Drug Discov] 2002 Jul; Vol. 1 (7), pp. 493-502. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Print ISSN: 1474-1776 (Print) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
